side effects of microdosing glp 1 GLP-1s: How (and Why) It Works Why Are Fit Guys Microdosing

The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype

Structural and molecular differences include: Amino acid composition : Semaglutide contains specific substitutions that confer DPP-4 resistance, whereas native GLP-1 is rapidly cleaved by this ubiquitous enzyme Albumin binding : The fatty acid side chain attached to lysine at position 26 in semaglutide enables prolonged circulation through albumin binding, a property absent in natural GLP-1 Molecular stability : Structural modifications protect semaglutide from enzymatic degradation and renal clearance that rapidly eliminate native GLP-1 From a clinical perspective, natural GLP-1 cannot be administered as a therapeutic agent due to its extremely short half-life, which would require continuous intravenous infusion for sustained effect

Its worth noting that cardiovascular mortality over two years was 50% to 70% higher in patients using sulfonylureas compared to those on metformin, according to research

Bharathi RV, Swetha S, Neerajaa J, et al

What Else is New with GLP-1s While much of the news about health insurance coverage for GLP-1s is bad, there's good news too